Lassa fever resources

PPE washing and drying station Lassa ward Owo

ISARIC is committed to strengthening the evidence base for Lassa fever therapeutics and improving case management. We have initiated a number of activities to address these knowledge gaps, which are conducted alongside a wide-range of partners and collaborators.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Publication library

Visit this section to find ISARIC’s articles, studies and more.

Latest news

Key inflammatory markers identified in COVID-19

Key inflammatory markers identified in COVID-19

ISARIC, supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the severity of COVID-19 and distinguish it from severe influenza.

Long COVID: tackling a multifaceted condition requires a multi- disciplinary approach

Long COVID: tackling a multifaceted condition requires a multi- disciplinary approach

The Lancet Infectious Diseases  published the GloPID-R and ISARIC Long COVID Forum Working Group’ letter, describing the content and discussions of the Long COVID Forum which took place on 9-10 December 2020.

Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data

“These regional differences in mortality reflect differences in access to better health care that already existed before the pandemic”, explains Fernando Bozza, study coordinator and researcher at the National Institute of Infectious Disease.